Imunon
IMNN
18 hedge funds and large institutions have $2.15M invested in Imunon in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
21% more call options, than puts
Call options by funds: $64K | Put options by funds: $53K
13% more capital invested
Capital invested by funds: $1.91M → $2.15M (+$245K)
6% more funds holding
Funds holding: 17 → 18 (+1)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$441K |
| 2 |
VF
Virtu Financial
New York
|
+$91.3K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$64.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.8K |
| 5 |
BlackRock
New York
|
+$14.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$85.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$37.9K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$37.1K |
| 4 |
MPWT
MassMutual Private Wealth & Trust
Windsor,
Connecticut
|
-$27.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$16.7K |
IMNN Hedge Fund Activity: Q2 2019 in Review
18 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2019, worth a combined $2.15M — up 13% from $1.91M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMNN positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $441K. The largest seller was Group One Trading, cutting an estimated $85.2K.
- 18 institutional investors held Imunon (IMNN) as of Q2 2019, up from 17 in Q1 2019.
- Funds reported $2.15M of Imunon stock for Q2 2019, up 13% quarter-over-quarter.
- 3 funds opened new Imunon positions in Q2 2019 and 2 closed out, a net change of +1 holder.
- The largest Imunon buyer in Q2 2019 was Vanguard Group, an estimated $441K added.
- The largest Imunon seller in Q2 2019 was Group One Trading, an estimated $85.2K sold.
Based on aggregated 13F filings for Q2 2019.